Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04
Published March 26, 2025 · Recall initiated: March 7, 2025
Summary
FDA records drug Class II recall D-0278-2025, published March 26, 2025 and initiated March 7, 2025. Recalling firm: Slate Run Pharmaceuticals; Status: Completed; Reported quantity: 56,790 bottles; Lot: Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Slate Run Pharmaceuticals
- Distributor
- Product was distributed to 8 distributors who may have further distribute the product nationwide.
- Lot
- Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, ForMarch 4, 2026
- FDACinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus,March 26, 2025
- FDADuloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health,March 26, 2025
- FDAPrasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,March 26, 2025
- FDAStryker CinchLock Flex Knotless Anchor with Inserter and Suture, REF CAT02643, Sterile EO, Rx Only MR Safe CEMarch 19, 2025
- FDADxI 9000 Access Immunoassay Analyzer, Catalog Number C11137March 19, 2025
Questions about this recall
Was Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04 recalled?
Yes. FDA published recall D-0278-2025 on March 26, 2025. Reported hazard: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
What should I do if I have this product?
Voluntary: Firm initiated · Letter